Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials-Reference-Cited by-同舟云学术

Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials

Published:2016-08-16 Issue:6 Volume:89 Page:994-1002
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Ferko Nicole¹,Ferrante Giuseppe²,Hasegawa James T.³,Schikorr Tanya³,Soleas Ireena M.¹,Hernandez John B.⁴,Sabaté Manel⁵,Kaiser Christoph⁶,Brugaletta Salvatore⁵,de la Torre Hernandez Jose Maria⁷,Galatius Soeren⁸,Cequier Angel⁹,Eberli Franz¹⁰,de Belder Adam¹¹,Serruys Patrick W.¹²,Valgimigli Marco¹³

Affiliation:

1. Health Economics and Reimbursement; Cornerstone Research Group Inc; Burlington, ON Canada

2. Interventional Cardiology, Department of Cardiovascular Medicine; Humanitas Clinical and Research Center; Rozzano Italy

3. Health Economics and Outcomes Research Department; Abbott Vascular; Santa Clara CA

4. Health Economics and Outcomes Research Department; Abbott Vascular and Abbott Electrophysiology; Santa Clara CA

5. Cardiology Department; University Hospital Clinic, IDIBAPS; Barcelona Spain

6. Department of Cardiology; University Hospital of Basel; Basel Switzerland

7. Interventional Cardiology Department; Hospital Marqués De Valdecilla; Santander Spain

8. Department of Cardiology; Gentofte Hospital; Hellerup Denmark

9. Heart Institute; University Hospital of Bellvitge; Barcelona Spain

10. Department of Cardiology; Stadtspital Triemli; Zurich Switzerland

11. Department of Cardiology; Brighton and Sussex University Hospitals; Brighton UK

12. Sussex Cardiac Centre; Thoraxcenter, Erasmus Medical Center; CE Rotterdam Netherlands

13. Department of Cardiology; University Hospital of Bern; Inselspital Bern Switzerland

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.26700/fullpdf

Reference37 articles.

1. The drug-eluting stent saga;Windecker;Circulation,2009

2. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials;Sabate;JACC Cardiovasc Interv,2014

3. Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis;Palmerini;J Am Coll Cardiol,2015

4. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease;Stone;N Engl J Med,2010

5. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis;Valgimigli;BMJ,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention;Expert Review of Pharmacoeconomics & Outcomes Research;2023-08-28

2. JCS/JSCVS 2018 Guideline on Revascularization of Stable Coronary Artery Disease;Circulation Journal;2022-02-25

3. Trends in the utilization and reimbursement of coronary revascularization in the United States Medicare population from 2010 to 2018;Catheterization and Cardiovascular Interventions;2021-03-24

4. Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease: A systematic review and meta-analysis;Atherosclerosis;2020-09

5. Cost-Effectiveness of Drug-Eluting Stents in Elderly Patients With Coronary Artery Disease: The SENIOR Trial;Value in Health;2019-12